WST
WEST PHARMACEUTICAL SERVICES INC
+5.66 (+1.56%)367.67USD162K成交股數25.9B市值47.1本益比(近四季)7.8股價營收比+13.8%營收年增(近四季)2026-10-22下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 872M+25% | 845M+13% | 805M+8% | 767M+9% | 698M+0% | 749M+0% | 747M-1% | 702M-2% | 695M | 747M | 754M | 717M |
| 營業成本 | 543M | 549M | 510M | 493M | 466M | 475M | 482M | 472M | 465M | 459M | 462M | 445M |
| 毛利 | 329M+42% | 296M+8% | 294M+11% | 274M+19% | 232M+1% | 274M-5% | 265M-9% | 230M-15% | 230M | 288M | 291M | 271M |
| 毛利率 | 37.7% | 35.1% | 36.6% | 35.7% | 33.2% | 36.5% | 35.4% | 32.8% | 33.1% | 38.6% | 38.7% | 37.9% |
| 研發費用 | 19.7M | 15.8M | 17.1M | 19.1M | 16.3M | 18.5M | 15.5M | 17.5M | 17.6M | 16.4M | 16.5M | 17.1M |
| 銷售管理費用 | 118M | 99.5M | 103M | 95.9M | 88.0M | 85.3M | 83.5M | 83.0M | 86.7M | 89.0M | 88.4M | 86.0M |
| 營業利益 | 179M+67% | 177M+11% | 168M+4% | 154M+22% | 107M-13% | 160M-10% | 161M-12% | 126M-19% | 123M | 177M | 183M | 155M |
| 營業利益率 | 20.5% | 21.0% | 20.8% | 20.1% | 15.3% | 21.3% | 21.6% | 18.0% | 17.7% | 23.7% | 24.2% | 21.7% |
| 稅後淨利 | 154M+71% | 139M+7% | 140M+3% | 132M+18% | 89.8M-22% | 130M-19% | 136M-12% | 111M-20% | 115M | 161M | 155M | 140M |
| 淨利率 | 17.7% | 16.4% | 17.4% | 17.2% | 12.9% | 17.4% | 18.2% | 15.9% | 16.6% | 21.6% | 20.6% | 19.5% |
| 稀釋 EPS | 2.15+75% | 1.92+8% | 1.92+4% | 1.82+21% | 1.23-21% | 1.78-17% | 1.85-10% | 1.51-18% | 1.55 | 2.14 | 2.06 | 1.85 |
| 稀釋股數 | 71.3M | 72.4M | 72.6M | 72.5M | 73.0M | 73.7M | 73.4M | 73.7M | 74.3M | 75.3M | 75.4M | 75.7M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 436M | 521M | 629M | 510M | 404M | 485M | 491M | 446M | 602M | 899M | 796M | 886M |
| 應收帳款 | 712M | 686M | 625M | 582M | 544M | 553M | 524M | 479M | 524M | 519M | 534M | 513M |
| 存貨 | 447M | 453M | 438M | 421M | 389M | 377M | 401M | 419M | 430M | 432M | 449M | 447M |
| 總資產 | 4.1B | 4.1B | 4.1B | 4.0B | 3.6B | 3.6B | 3.7B | 3.5B | 3.6B | 3.8B | 3.7B | 3.7B |
| 有息負債 | 203M | 203M | 203M | 203M | 203M | 203M | 203M | 72.9M | 72.8M | 152M | 206M | 206M |
| 總負債 | 1.1B | 1.1B | 1.1B | 1.0B | 935M | 961M | 923M | 913M | 922M | 887M | 923M | 947M |
| 股東權益 | 3.0B | 3.0B | 3.1B | 2.9B | 2.7B | 2.7B | 2.8B | 2.6B | 2.7B | 2.9B | 2.7B | 2.8B |
| 負債比 | 26.6% | 27.2% | 25.7% | 25.9% | 25.8% | 26.4% | 25.1% | 26.2% | 25.6% | 23.6% | 25.1% | 25.4% |
| 淨現金(現金 − 有息負債) | 233M | 319M | 426M | 307M | 202M | 282M | 288M | 373M | 529M | 747M | 591M | 680M |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | 89.9M | – | – | 129M+9% | – | – | – | 118M | – | – | 138M |
| 資本支出 | – | 42.7M | – | – | 71.3M | – | – | – | 90.6M | – | – | 82.1M |
| 自由現金流 | – | 47.2M | – | – | 58.1M+111% | – | – | – | 27.6M | – | – | 56.0M |
| 折舊攤銷 | 46.2M | 45.2M | 43.0M | 41.4M | 40.0M | 40.7M | 40.2M | 38.9M | 35.6M | – | – | – |
| 買回庫藏股 | – | 298M | – | – | 134M | – | – | – | 267M | – | – | 60.1M |
| 現金股利 | – | 15.8M | – | – | 15.2M | – | – | – | 14.7M | – | – | 14.1M |
| 自由現金流率 | – | 5.6% | – | – | 8.3% | – | – | – | 4.0% | – | – | 7.8% |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 3.1B
| Proprietary Products | 2.5B | 81.1% | +6.8% |
|---|---|---|---|
| Contract Manufactured Products | 582M | 18.9% | +4.2% |
地區2025 年度 · 3.1B
| 美國 | 1.3B | 43.3% | +8.0% |
|---|---|---|---|
| Other Europe Countries | 451M | 14.7% | +17.0% |
| 德國 | 380M | 12.4% | +2.1% |
| 其他國家 | 353M | 11.5% | +4.2% |
| 愛爾蘭 | 333M | 10.8% | +3.1% |
| 法國 | 227M | 7.4% | -6.4% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 3.1B | +6.3% | 494M | 16.1% | 6.79 | 469M |
| FY2024 | 2.9B | -1.9% | 493M | 17.0% | 6.69 | 276M |
| FY2023 | 2.9B | +2.2% | 593M | 20.1% | 7.88 | 415M |
| FY2022 | 2.9B | +2.0% | 586M | 20.3% | 7.73 | 439M |
| FY2021 | 2.8B | +31.9% | 662M | 23.4% | 8.67 | 331M |
| FY2020 | 2.1B | +16.7% | 346M | 16.1% | 4.57 | 298M |
| FY2019 | 1.8B | +7.1% | 242M | 13.1% | 3.21 | 241M |
| FY2018 | 1.7B | – | 207M | 12.0% | 2.74 | 184M |